Methods for inhibiting the binding of endosialin to ligands

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2682726

The invention provides methods for inhibiting the interaction of endosialin with endosialin ligands. The inhibition is effectuated by blocking the interaction of cell-surface expressed endosialin with ligands such as fibronectin and collagen with the anti-endosialin antibody M4, also known as FB5.

L'invention concerne des procédés pour inhiber l'interaction de l'endosialine avec des ligands d'endosialine. L'inhibition est effectuée au niveau génétique, par l'inhibition de l'expression du gène d'endosialine, et au niveau protéinique, par le blocage de l'interaction de l'endosialine exprimée à la surface des cellules avec des ligands tels que la fibronectine et le collagène. L'invention concerne des procédés pour identifier des inhibiteurs de l'interaction de l'endosialine avec des ligands d'endosialine. L'invention concerne également des procédés pour inhiber l'angiogenèse et la néovascularisation in vivo et in vitro.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods for inhibiting the binding of endosialin to ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for inhibiting the binding of endosialin to ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting the binding of endosialin to ligands will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1886199

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.